What types of stem cells can be used for stroke patients?
Cerebral infarction refers to cerebral infarction (cerebral infarction). Patients with cerebral infarction can generally receive mesenchymal stem cell therapy. The specific details are as follows:
Cerebral infarction usually refers to ischemic necrosis or softening of local brain tissue caused by impaired cerebral blood supply, ischemia, and hypoxia, which is a common neurological condition. Patients may exhibit various clinical symptoms and signs depending on the location and size of the lesion, such as hemiplegia, hemianopia, and speech dysfunction. In more severe cases, bulbar palsy, quadriplegia, disturbances in consciousness, cerebral edema, and increased intracranial pressure may occur. Mesenchymal stem cells can be administered at hospitals; these are typically multipotent stem cells capable of differentiating into neural cells, secreting neurotrophic factors, and modulating bodily functions, thus promoting neurogenesis, angiogenesis, and regulation of immune-inflammatory responses. They can also be combined with exogenous transplantation, genome editing, and biomaterials to facilitate tissue repair.
If patients experience any discomfort, they should promptly seek medical treatment. Adequate rest is recommended, and excessive mental exertion should be avoided.